Chronic Treatment with the Probiotics Lacticaseibacillus rhamnosus GG and Bifidobacterium lactis BB12 Attenuates Motor Impairment, Striatal Microglial Activation, and Dopaminergic Loss in Rats with 6-Hydroxydopamine-induced Hemiparkinsonism

Publication | Closed Access

DOI

Citations

References

2022

Year

Sergio G. Cuevas-Carbonell, Lizbeth Vásquez-Celaya, Daniel García-López, Diego Granados-Patrón, María del Rosario García‐Miss, Fernando J. Álvarez-Cervera, Mirza Mut‐Martín, Irving Parra, Liliana Mendieta, Humberto Salgado,

Neuroscience

Neurodegenerative Diseases6-Hydroxydopamine-induced HemiparkinsonismMedicineDopaminergic LossNeuropharmacologyBrain-immune InteractionNeuroprotectionNeurologyNeuroscienceCentral Nervous SystemDopamineChronic TreatmentPharmacologyNeuroimmunologyNeuroinflammation